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To the Editor: Sunburn is a biologic indicator of acute overexposure to ultraviolet (UV) 
radiation, and sunburn at any age is associated with an increased risk for melanoma.1 
Tracking changes in the national prevalence of sunburn over time can provide insight to our 
nation’s progress toward increasing adequate use of sun protection and reducing skin cancer 
risk at a population level.2 We examined changes over time in sunburn among US adults 
during 2005–2015.
We analyzed data from the 2005, 2010, and 2015 National Health Interview Survey, a cross-
sectional, nationally representative sample of the US civilian population aged ≥18 years 
(https://www.cdc.gov/nchs/nhis/). Respondents were asked to report the number of sunburns 
they experienced during the preceding 12 months. We estimated the percentage of adults 
who experienced ≥1 sunburn each year and the mean number of sunburns among those who 
were sunburned overall and by sex, age group, race/ethnicity, and US region. We assessed 
differences in sunburn between survey years by using logistic regressions to calculate 
adjusted prevalence ratios overall and for each demographic subgroup. Annual unconditional 
response rates were 55.2%−69.0%, and sample sizes were 27,157–33,672 persons. We used 
SAS-callable SUDAAN version 11.0 (Research Triangle Institute, Research Triangle Park, 
NC) for the analyses to account for the complex sampling design and for nonresponse.
Each year, more than one third of adults experienced sunburn (Table I). The mean number of 
sunburns (among those reporting sunburn) ranged from 2.37 (95% confidence interval [CI] 
2.25–2.48) in 2010 to 2.62 (95% CI 2.39–2.84) in 2015. A higher percentage of non-
Hispanic white adults experienced sunburn compared with other racial/ethnic groups (P <.
001), and the percentage of adults experiencing sunburn tended to decrease with increasing 
age (P < .001). Among all adults, sunburn increased significantly during 2005–2010 
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(adjusted prevalence ratio [APR] 1.13, 95% CI 1.09–1.17) and during 2005–2015 (APR 
1.09, 95% CI 1.05–1.14). Sunburn did not change significantly during 2010–2015. Similar 
patterns occurred across most demographic subgroups. However, during 2005–2015, 
sunburn increased significantly only among females, 50–59-year-olds, 60–69-year-olds, 
non-Hispanic whites, and those living in the South (Fig 1). There were no significant 
changes in the mean number of sunburns over time.
Study limitations include reliance on self-reported information, which is subject to error, and 
generalizability to only the noninstitutionalized, civilian adult population. The large sample 
size warrants caution when interpreting statistically significant results with small absolute 
differences between years.
Overall, we found little change in sunburn prevalence during 2005–2015. Although sunburn 
is most prevalent among non-Hispanic white adults, heterogeneity in skin type exists within 
racial and ethnic groups, and these data indicate that all demographic groups experience 
preventable overexposure to UV radiation. Without future decreases in sunburn, skin cancer 
rates will likely continue to increase in the decades to come.3 Evidence-based interventions 
to reduce UV exposure and increase sun protection are available.2,4,5 However, more efforts 
are needed to help communities adapt and adopt these strategies and programs to meet their 
unique needs and maximize the likelihood of sustainability over time.
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Fig 1. 
APRs for ≥1 sunburns among US adults in 2015 versus 2005 overall and by sex, age, race/
ethnicity, and US region. APRs were adjusted for demographic characteristics by using 
logistic regression models with predicted marginal probabilities. The APRs for total were 
adjusted for sex, age groups, race/ethnicity, and US region in the model. The APRs for male 
and female were adjusted for age groups, race/ethnicity, and US region in the model. The 
APRs for the 5 age groups were adjusted for sex, race/ethnicity, and US region in the model. 
The APRs for the racial/ethnic groups were adjusted for sex, age groups, and US region in 
the model. The APRs for the US regions were adjusted for sex, age groups, and race/
ethnicity. The category other non-Hispanic races included non-Hispanic respondents who 
were American Indian, Alaska Native, Asian, or multiple races. APR, Adjusted prevalence 
ratio. *APR is statistically significant (P <.01).
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